Summary unavailable.

Questions

Question 1

What is the primary general use of antiplatelet agents as described in the text?

View answer and explanation
Question 2

According to the 'General Action and Information' section, what is a key mechanism of antiplatelet agents?

View answer and explanation
Question 3

Which of the following conditions is listed as a contraindication for the use of antiplatelet agents?

View answer and explanation
Question 4

What is the potential consequence of using antiplatelet agents concurrently with warfarin?

View answer and explanation
Question 5

Which set of antiplatelet agents is specifically identified for the management of acute coronary syndromes?

View answer and explanation
Question 6

What is a key nursing assessment for a patient taking antiplatelet agents?

View answer and explanation
Question 7

What is the primary desired outcome of antiplatelet therapy?

View answer and explanation
Question 8

In which patient population is cautious use of antiplatelet agents advised due to risks of bleeding?

View answer and explanation
Question 9

According to the 'Patient/Family Teaching' section, what action should a patient take if they notice any bleeding?

View answer and explanation
Question 10

For which type of administration is the use of an infusion pump recommended for antiplatelet agents?

View answer and explanation
Question 11

Which of the following is NOT listed as a contraindication for antiplatelet agents?

View answer and explanation
Question 12

The text states that agents like eptifibatide, abciximab, and tirofiban are often used concurrently with which two other classes of drugs?

View answer and explanation
Question 13

In which specific patient populations is the safety of antiplatelet agents stated to be 'not established'?

View answer and explanation
Question 14

The concurrent use of antiplatelet agents with heparin may lead to what adverse effect?

View answer and explanation
Question 15

What periodic assessment should be conducted for a patient taking antiplatelet agents, according to the 'Assessment' section?

View answer and explanation
Question 16

Which of the following is listed as an agent used to prevent MI or stroke?

View answer and explanation
Question 17

Which of the potential nursing diagnoses is related to the primary adverse effect of antiplatelet agents?

View answer and explanation
Question 18

Antiplatelet agents prolong bleeding time by what mechanism?

View answer and explanation
Question 19

What is the reason for using antiplatelet agents cautiously in a patient with a history of ulcer disease?

View answer and explanation
Question 20

The concurrent use of antiplatelet agents with which class of drugs, besides NSAIDs and anticoagulants, may increase the risk of bleeding?

View answer and explanation
Question 21

Which of the following agents is NOT in the same therapeutic category as aspirin and clopidogrel for preventing MI or stroke?

View answer and explanation
Question 22

What is the primary risk associated with the nursing diagnosis 'Risk for injury' in a patient on antiplatelet agents?

View answer and explanation
Question 23

How many specific antiplatelet agents are listed in the text as being used for the management of acute coronary syndromes?

View answer and explanation
Question 24

Which of the following is not listed as a potential nursing diagnosis for a patient on antiplatelet agents?

View answer and explanation
Question 25

The primary goal of antiplatelet therapy is to prevent which of the following outcomes in at-risk patients?

View answer and explanation
Question 26

How many drug classes are mentioned in the 'Interactions' section that may increase the risk of bleeding when used with antiplatelet agents?

View answer and explanation
Question 27

What is the primary action of agents such as aspirin and prasugrel?

View answer and explanation
Question 28

In addition to a history of GI bleeding or ulcer disease, what other condition is mentioned as a precaution for antiplatelet use?

View answer and explanation
Question 29

What does the text imply is the reason to assess for symptoms of peripheral arterial disease in a patient on antiplatelet agents?

View answer and explanation
Question 30

How many potential nursing diagnoses are listed for antiplatelet agents in the provided text?

View answer and explanation
Question 31

Which of the following is NOT a general use for antiplatelet agents according to the text?

View answer and explanation
Question 32

What is the clinical significance of antiplatelet agents prolonging bleeding time?

View answer and explanation
Question 33

Active bleeding is listed as a contraindication for antiplatelet agents. What is the most likely reason for this?

View answer and explanation
Question 34

Which agent is listed as an antiplatelet agent alongside aspirin, clopidogrel, and ticlopidine?

View answer and explanation
Question 35

The nursing diagnosis 'Ineffective tissue perfusion' for a patient on antiplatelet agents relates to what?

View answer and explanation
Question 36

Which condition is listed in the 'Precautions' section for antiplatelet agents?

View answer and explanation
Question 37

What is the primary reason to ensure accurate dosage of continuous infusions of antiplatelet agents with an infusion pump?

View answer and explanation
Question 38

How many specific antiplatelet agents are listed for the general prevention of MI or stroke?

View answer and explanation
Question 39

The text states antiplatelet agents are used to 'treat and prevent' thromboembolic events. What is the most likely way they 'treat' an event like an MI?

View answer and explanation
Question 40

The nursing assessment for a patient on antiplatelet therapy includes checking for symptoms of which of the following?

View answer and explanation
Question 41

What is the primary mechanism of action for antiplatelet agents?

View answer and explanation
Question 42

Which statement best describes the use of antiplatelet agents in patients with a history of GI bleeding?

View answer and explanation
Question 43

The interaction between antiplatelet agents and thrombolytics results in an increased risk of what?

View answer and explanation
Question 44

What is the key desired outcome for a patient taking an antiplatelet agent for secondary prevention after a stroke?

View answer and explanation
Question 45

How many items are listed as contraindications for antiplatelet agents?

View answer and explanation
Question 46

The text mentions that some antiplatelet agents are used 'concurrently/sequentially with anticoagulants and thrombolytics.' Which agents are specified for this use?

View answer and explanation
Question 47

Which of the following is NOT listed as a precaution for the use of antiplatelet agents?

View answer and explanation
Question 48

The primary purpose of assessing a patient on antiplatelet therapy for symptoms of a stroke is to evaluate what?

View answer and explanation
Question 49

How many of the listed antiplatelet agents for prevention start with the letter 't'?

View answer and explanation
Question 50

What is the most likely reason that recent surgery is a contraindication for antiplatelet agents?

View answer and explanation

Other chapters

HOW TO USE DAVIS'S DRUG GUIDE FOR NURSESEVIDENCE-BASED PRACTICE AND PHARMACOTHERAPEUTICS: Implications for NursesPHARMACOGENOMICSMEDICATION ERRORS: Improving Practices and Patient SafetyDETECTING AND MANAGING ADVERSE DRUG REACTIONSOVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS)SPECIAL DOSING CONSIDERATIONSTHE CYTOCHROME P450 SYSTEMEDUCATING PATIENTS ABOUT SAFE MEDICATION USEAnti-Alzheimer's agentsAntianemicsAntianginalsAntianxiety agentsAntiarrhythmicsAntiasthmaticsAnticholinergicsAnticoagulantsAnticonvulsantsAntidepressantsAntidiabeticsAntidiarrhealsAntiemeticsAntifungalsAntihistaminesAntihypertensivesAnti-infectivesAntineoplasticsAntiparkinson agentsAntipsychoticsAntipyreticsAntirheumaticsAntiulcer agentsAntiviralsBeta blockersBone resorption inhibitorsBronchodilatorsCalcium channel blockersCentral nervous system stimulantsCorticosteroidsDiureticsHormonesImmunosuppressantsLaxativesLipid lowering agentsMinerals/electrolytes/pH modifiersNonopioid analgesicsNonsteroidal anti-inflammatory agentsOpioid analgesicsSedative/hypnoticsSkeletal muscle relaxantsThrombolyticsVaccines/immunizing agentsVitaminsDRUGS APPROVED IN CANADANATURAL/HERBAL PRODUCTSMEDICATION SAFETY TOOLSAppendix A. Recent Drug ApprovalsAppendix E. Administering Medications to ChildrenAppendix G. Pediatric Dosage CalculationsAppendix I. Controlled Substance SchedulesAppendix L. Insulins and Insulin TherapyAppendix M. Canadian and U.S. Pharmaceutical PracticesAppendix N. Routine Pediatric and Adult Immunizations